0.8571 USD
-0.01 (-1.39%)
0.83 USD
-0.03 (-3.16%)
ChartMill assigns a Buy % Consensus number of 80% to BCAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 1090.06% above the current price.
BCAB was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BCAB.
In the previous month the buy percentage consensus was at a similar level.
BCAB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-13 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-03-31 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | JMP Securities | Reiterate | Outperform -> Outperform |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-04-03 | JP Morgan | Maintains | Overweight |
| 2023-03-28 | BTIG | Maintains | Buy |
| 2023-03-27 | JMP Securities | Maintains | Outperform |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
| 2023-03-24 | Credit Suisse | Reiterate | Neutral |
| 2023-03-24 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-04 | Credit Suisse | Maintains | Neutral |
| 2022-09-15 | JMP Securities | Initiate | Market Outperform |
BIOATLA INC / BCAB FAQ
What is the average price target for BIOATLA INC (BCAB) stock?
9 analysts have analysed BCAB and the average price target is 10.2 USD. This implies a price increase of 1090.06% is expected in the next year compared to the current price of 0.8571.
What is the consensus rating for BIOATLA INC (BCAB) stock?
The consensus rating for BIOATLA INC (BCAB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for BIOATLA INC stock?
The number of analysts covering BIOATLA INC (BCAB) is 9.